Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
rare diseases
Pharma
X4 snags FDA approval for its first drug Xolremdi
X4 Pharmaceuticals has made its commercial debut thanks to Monday’s FDA approval of the company’s CXCR4 inhibitor Xolremdi in WHIM syndrome.
Fraiser Kansteiner
Apr 29, 2024 11:28am
Biogen's fortunes are trending upward thanks to its new launches
Apr 24, 2024 11:24am
Experts paint tough path ahead of Alnylam's key ATTR-CM readout
Apr 22, 2024 10:55am
AZ's Alexion debuts short film highlighting NMOSD community
Apr 18, 2024 2:16pm
Amylyx to pull failed ALS drug from market, cut 70% of staff
Apr 4, 2024 10:06am
FDA expands AZ's Ultomiris to NMOSD after prior rejection
Mar 25, 2024 10:31am